Reguladores europeos investigan el riesgo de ideación suicida con unos populares fármacos para perder peso
MARTES, 11 de julio de 2023 (HealthDay News) — La Agencia Europea de Medicamentos (European Medicines Agency, EMA) está investigando preocupaciones de que Ozempic y Saxenda, unos populares medicamentos para perder preso, pudieran estar vinculados con…
Learn MoreLa intensa ola de calor es un peligro para las personas con demencia
MARTES, 11 de julio de 2023 (HealthDay News) — A medida que un calor extremo continúa arropando a numerosas partes de Estados Unidos, los estadounidenses con demencia podrían tener dificultades particulares. “Las temperaturas y los índices de calor d…
Learn MoreFibromyalgia Tied to Higher Risk of Death From Many Causes
WEDNESDAY, July 12, 2023 (HealthDay News) — For years, people with the widespread pain disorder fibromyalgia were told their symptoms were all in their heads, but now the illness is being taken much more seriously with good reason.Folks with fibromya…
Learn MoreIncome, Healthy Food Access Linked to Life Expectancy
WEDNESDAY, July 12, 2023 (HealthDay News) — Income and healthy food accessibility are associated with life expectancy, with the lowest life expectancy in low-income/low-access census tracts, according to a study published online June 28 in the Journa…
Learn MorePrevalence of Atopic Diseases Increased in Sexually Diverse Individuals
WEDNESDAY, July 12, 2023 (HealthDay News) — The prevalence of atopic diseases, including atopic dermatitis, is increased in sexually diverse people, including those who identify as lesbian, gay, or bisexual, according to a research letter published o…
Learn MoreTreatment Effect of Tofacitinib, Adalimumab Compared in RA
WEDNESDAY, July 12, 2023 (HealthDay News) — For adults with rheumatoid arthritis (RA), there is a modest reduction in the mean Disease Activity Score in 28 joints using C-reactive protein (DAS28-CRP) at three months for patients receiving tofacitinib…
Learn MoreCoexisting Conditions Impact Survival in Oral Cancer
WEDNESDAY, July 12, 2023 (HealthDay News) — For patients with oral squamous cell carcinoma, excluding the effects of coexisting conditions can lead to underestimation or overestimation of survival, according to a study published online July 10 in JAM…
Learn MoreProlonged Time to Postop Radiation Linked to Worse Survival in Oral Cavity Cancer
WEDNESDAY, July 12, 2023 (HealthDay News) — For patients with oral cavity cancer, prolonged surgery to initiation of postoperative radiation therapy (S-PORT) is associated with worse overall survival, according to a study published online July 9 in J…
Learn MoreLearning Disabilities in U.S. Youth Remained Steady From 1997 to 2021
WEDNESDAY, July 12, 2023 (HealthDay News) — The prevalence of learning disabilities among youth aged 6 to 17 years remained steady from 1997 to 2021, according to a research letter published online July 10 in JAMA Pediatrics.Yanmei Li, from Guangdong…
Learn More